Top

Published in:

Open Access 08-05-2024

Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice

Authors: Noha A. Mowaad, Rania Elgohary, Shaimaa ElShebiney

Published in: Cardiovascular Toxicology | Issue 6/2024

Abstract

Adolescents commonly co-abuse many drugs including anabolic androgenic steroids either they are athletes or non-athletes. Stanozolol is the major anabolic used in recent years and was reported grouped with cannabis. The current study aimed at evaluating the biochemical and histopathological changes related to the hypertrophic effects of stanozolol and/or cannabis whether in condition of exercise practice or sedentary conditions. Adult male Wistar albino rats received either stanozolol (5 mg/kg, s.c), cannabis (10 mg/kg, i.p.), and a combination of both once daily for two months. Swimming exercise protocol was applied as a training model. Relative heart weight, oxidative stress biomarkers, cardiac tissue fibrotic markers were evaluated. Left ventricular morphometric analysis and collagen quantification was done. The combined treatment exhibited serious detrimental effects on the heart tissues. It increased heart tissue fibrotic markers (Masson’s trichrome stain (p < 0.001), cardiac COL3 (p < 0.0001), and VEGF-A (p < 0.05)), lowered heart glutathione levels (p < 0.05) and dramatically elevated oxidative stress (increased malondialdehyde (p < 0.0001) and 8-OHDG (p < 0.0001)). Training was not ameliorating for the observed effects. Misuse of cannabis and stanozolol resulted in more hypertrophic consequences of the heart than either drug alone, which were at least largely assigned to oxidative stress, heart tissue fibrotic indicators, histological alterations, and morphometric changes.

Kennedy, M. C. (2017). Cannabis: exercise performance and sport. A systematic review. Journal of Science and Medicine in Sport, 20(9), 825–829.PubMedCrossRef

Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., & Kleijnen, J. (2015). Cannabinoids for medical use. JAMA, 313(24), 2.CrossRef

Zeiger, J. S., Silvers, W. S., Fleegler, E. M., & Zeiger, R. S. (2019). Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes. Journal of Cannabis Research. https://doi.org/10.1186/s42238-019-0006-9CrossRefPubMedPubMedCentral

Brisola-Santos, M. B., Gallinaro, J. G. D. M. E., Gil, F., Sampaio-Junior, B., Marin, M. C. D., De Andrade, A. G., Richter, K. P., Glick, I. D., Baltieri, D. A., & Castaldelli-Maia, J. M. (2016). Prevalence and correlates of cannabis use among athletes—A systematic review. American Journal on Addictions, 25(7), 518.PubMedCrossRef

Burr, J. F., Cheung, C. P., Kasper, A. M., Gillham, S. H., & Close, G. L. (2021). Cannabis and athletic performance. Sports Medicine (Auckland, N. Z.), 51(Suppl 1), 75.PubMedCrossRef

Kanayama, G., Hudson, J. I., & Pope, H. G., Jr. (2008). Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98, 1–12. https://doi.org/10.1016/j.drugalcdep.2008.05.004CrossRefPubMedPubMedCentral

Maravelias, C., Dona, A., Stefanidou, M., & Spiliopoulou, C. (2005). Adverse effects of anabolic steroids in athletes. A constant threat. Toxicology Letters, 158, 167–175.PubMedCrossRef

Park-Lee, R. E. A. (2019) Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. HHS Publ No PEP19-5068, NSDUH Ser H-54. 170, 51–8. https://www.samhsa.gov/data/

Vicencio, J. M., Ibarra, C., Estrada, M., Chiong, M., Soto, D. P. V., Diaz-Araya, G., Jaimovich, E., & Lavandero, S. (2006). Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology, 47, 1386–1413.CrossRef

10.

WADA. (2021). Anti-doping testing figures (pp. 1–22). https://www.wada-ama.org/sites/default/files/202.-01/2021_anti-doping_testing_figures_en.pd.

11.

DEA. Drug scheduling. Retrieved from https://www.dea.gov/drug-information/drug-scheduling. 1 Aug.

12.

Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocrine Reviews, 35(3), 341.PubMedCrossRef

13.

Goyal, H., Awad, H. H., & Ghali, J. K. (2017). Role of cannabis in cardiovascular disorders. Journal of Thoracic Disease, 9(7), 2079–2092.PubMedPubMedCentralCrossRef

14.

Erickson, K., Hillman, C., Stillman, C., Ballard, R., Bloodgood, B., Conroy, D., et al. (2020). The 2018 physical activity guidelines. Medicine & Science in Sports & Exercise, 51(6), 1242–1251.CrossRef

15.

Kayacan, Y., Çetinkaya, A., Yazar, H., & Makaracı, Y. (2021). Oxidative stress response to different exercise intensity with an automated assay: Thiol/disulphide homeostasis. Archives of Physiology and Biochemistry, 127(6), 504–508. https://doi.org/10.1080/13813455.2019.1651868CrossRefPubMed

16.

Kayacan, Y., Kola, A. Z., Guandalini, S., Yazar, H., & Söğüt, M. Ü. (2022). The use of probiotics combined with exercise affects thiol/disulfide homeostasis, an oxidative stress parameter. Nutrients, 14(17), 3555.PubMedPubMedCentralCrossRef

17.

Varvel, S., Thomas, B. F., & Lichtman, A. H. (2005). Δ9-Tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. Journal of Pharmacology and Experimental Therapeutics, 314, 329–337.PubMedCrossRef

18.

Tucci, P., Morgese, M. G., Colaianna, M., Zotti, M., Schiavone, S., Cuomo, V., et al. (2012). Neurochemical consequence of steroid abuse: Stanozolol-induced monoaminergic changes. Steroids, 77(3), 269–275.PubMedCrossRef

19.

Barbosa dos Santos, G., José Machado Rodrigues, M., Maria Gonçalves, E., Cristina Cintra Gomes Marcondes, M., & Arcanjo Areas, M. (2013). Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise. Eurasian J Med., 45(3), 155.PubMedPubMedCentralCrossRef

20.

Uchiyama, M., & Mihara, M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86, 271–278.PubMedCrossRef

21.

Beutler, E., Duron, O., & Kelly, B. M. (1963). Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine, 61, 882–888.PubMed

22.

Miranda, K. M., Espey, M. G., & Wink, D. A. (2001). A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide, 5, 62–71.PubMedCrossRef

23.

Culling, C. F. A. (2013). Handbook of histopathological and histochemical techniques (3rd ed.). London: Butterworths.

24.

Sivalokanathan, S., Małek, ŁA., & Malhotra, A. (2021). The cardiac effects of performance-enhancing medications: Caffeine vs. anabolic androgenic steroids. Diagnostics., 11(2), 324.PubMedPubMedCentralCrossRef

25.

Turnock, L. A. (2021). Polydrug use and drug market intersections within powerlifting cultures in remote South-West England. Performance Enhancement & Health, 8(4), 100186.CrossRef

26.

WADA. (2023). Anti-doping testing figures (pp. 19–22). https://www.wada-ama.org/sites/default/files/2023-01/2021_anti-doping_testing_figures_en.pdfo.

27.

Frati, P., Busardò, F. P., Cipolloni, L., De, D. E., & Fineschi, V. (2015). Anabolic androgenic steroid (AAS) related deaths: Autoptic, HISTOPATHOLOGICAL AND TOXICOLOGICAL FINDINGS. Current Neuropharmacology, 13(1), 146.PubMedPubMedCentralCrossRef

28.

Fineschi, V., Baroldi, G., Monciotti, F., Reattelli, L. P., & Turillazzi, E. (2001). Anabolic steroid abuse and cardiac sudden death: A pathologic study. Archives of Pathology and Laboratory Medicine, 125(2), 253–255.PubMedCrossRef

29.

Torrisi, M., Pennisi, G., Russo, I., Amico, F., Esposito, M., Liberto, A., et al. (2020). Sudden cardiac death in anabolic-androgenic steroid users: A literature review. Med, 56(11), 587.

30.

Marsh, J. D., Lehmann, M. H., Ritchie, R. H., Gwathmey, J. K., Green, G. E., & Schiebinger, R. J. (1998). Androgen receptors mediate cardiac hypertrophy in cardiac myocytes. Circulation, 98, 256–261.PubMedCrossRef

31.

Sheffield-Moore, M., Urban, R. J., Wolf, S. E., Jiang, J., Catlin, D. H., Herndon, D. N., et al. (1999). Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. Journal of Clinical Endocrinology and Metabolism, 84(8), 2705–2711.PubMed

32.

Sinha-Hikim, I., Taylor, W. E., Gonzalez-Cadavid, N. F., Zheng, W., & Bhasin, S. (2004). Androgen receptor in human skeletal muscle and cultured muscle satellite cells: Up-regulation by androgen treatment. Journal of Clinical Endocrinology and Metabolism, 89(10), 5245–5255.PubMedCrossRef

33.

Payne, J. R., Kotwinski, P. J., & Montgomery, H. E. (2004). Cardiac effects of anabolic steroids. Heart, 90(5), 473–475.PubMedPubMedCentralCrossRef

34.

Urhausen, A., Albers, T., & Kindermann, W. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, 90(5), 496–501.PubMedPubMedCentralCrossRef

35.

Beutel, A., Bergamaschi, C. T., & Campos, R. R. (2005). Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats. Journal of Steroid Biochemistry and Molecular Biology, 93(1), 43–48.PubMedCrossRef

36.

Stojko, M., Nocoń, J., Piłat, P., Szpila, G., Smolarczyk, J., Żmudka, K., et al. (2023). Innovative reports on the effects of anabolic androgenic steroid abuse—How to lose your mind for the love of sport. Medicina (B Aires)., 59(8), 1439.CrossRef

37.

Zebrowska, A., Sadowska-Krȩpa, E., Jagsz, S., Kłapcińska, B., & Langfort, J. (2017). Cardiac hypertrophy and IGF-1 response to testosterone propionate treatment in trained male rats. Open Life Sci., 12(1), 120–127.CrossRef

38.

Vingren, J. L., Kraemer, W. J. R. N., Anderson, J. M., & Volek, J. S. M. C. (2010). Testosterone physiology in resistance exercise and training: The up-stream regulatory elements. Sports Medicine, 40(12), 103.CrossRef

39.

Lizotte, E., Grandy, S. A., Tremblay, A., Allen, B. G., & Fiset, C. (2009). Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cellular Physiology and Biochemistry, 23(1–3), 75–86.PubMedCrossRef

40.

Mohamed, H. Z. E., & Mohamed, H. K. (2022). Histological and immuno histochemical studies of the effects of administration of anabolic androgenic steroids alone and in concomitant with training exercise on the adult male rats skeletal muscles. Egyptian Journal of Histology, 45(1), 36.

41.

Elgendy, H.A.-E., Alhawary, A.A.-E., El-Shahat, M.A.-E., & Ali, A. T. (2018). Effect of anabolic steroids on the cardiac and skeletal muscles of adult male rats. International Journal of Clinical and Developmental Anatomy, 4, 1–14.CrossRef

42.

Smit, D. L., Voogel, A. J., den Heijer, M., & de Ronde, W. (2021). anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction. Echocardiography results of the HAARLEM study. Frontiers in Reproductive Health, 3, 732318.PubMedPubMedCentralCrossRef

43.

Paulis, L., & Šimko, F. (2007). Blood pressure modulation and cardiovascular protection by melatonin: Potential mechanisms behind. Physiological Research, 56(6), 671–684.PubMedCrossRef

44.

Rocha, F. L., Carmo, E. C., Roque, F. R., Hashimoto, N. Y., Rossoni, L. V., Frimm, C., Anéas, I., Negrão, C. E., Krieger, J. E., & Oliveira, E. (2007). Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. American Journal of Physiology-Heart and Circulatory Physiology, 293(6), H3575–H3583.PubMedCrossRef

45.

Lee, C.-H., Lee, W.-C., Chang, S.-H., Wen, M.-S., & Hung, K.-C. (2015). The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: A link between left ventricular end-diastolic pressure and cardiovascular events. PLoS ONE, 10, 1. https://doi.org/10.1371/journal.pone.0114097CrossRef

46.

Nikolov, A., & Popovski, N. (2022). Extracellular matrix in heart disease: Focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: A concise review. Metabolites, 12, 4. https://doi.org/10.3390/metabo12040297CrossRef

47.

Kong, P., Christia, P., & Frangogiannis, N. G. (2014). The pathogenesis of cardiac fibrosis. Cellular and Molecular Life Sciences, 71, 4. https://doi.org/10.1007/s00018-013-1349-6CrossRef

48.

Franquni, J., do Nascimento, A., de Lima, E., et al. (2013). Nandrolone decanoate determines cardiac remodelling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold-Jarisch reflex, resulting in the development of hypertension. Steroids, 78(3), 379.PubMedCrossRef

49.

Braile, M., Marcella, S., Cristinziano, L., Galdiero, M. R., Modestino, L., Ferrara, A. L., et al. (2020). VEGF-A in cardiomyocytes and heart diseases. International Journal of Molecular Sciences, 21(15), 5294. https://doi.org/10.3390/ijms21155294CrossRefPubMedPubMedCentral

50.

Zhao, T., Zhao, W., Chen, Y., Ahokas, R. A., & Sun, Y. (2010). Vascular endothelial growth factor (VEGF)-A: Role on cardiac angiogenesis following myocardial infarction. Microvascular Research, 80, 2. https://doi.org/10.1016/j.mvr.2010.03.014CrossRef

51.

Heba, G., Krzeminski, T., Porc, M., Grzyb, J., & Dembinska-Kiec, A. (2001). Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats. Journal of Physiology and Pharmacology, 52, 1.

52.

Ikeda, Y., Aihara, K. I., Sato, T., Akaike, M., Yoshizumi, M., Suzaki, Y., et al. (2005). Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. Journal of Biological Chemistry, 280(33), 29661–29666.PubMedCrossRef

53.

Wilson, C., Contreras-Ferrat, A., Venegas, N., Osorio-Fuentealba, C., Pávez, M., Montoya, K., et al. (2013). Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes. Journal of Cellular Physiology, 228(12), 2399–2407.PubMedCrossRef

54.

Li, X., Wang, G., Qili, M., Liang, H., Li, T., Xiaoqiang, E., et al. (2018). Aspirin reduces cardiac interstitial fibrosis by inhibiting Erk1/2-Serpine2 and P-Akt signalling pathways. Cellular Physiology and Biochemistry, 45(5), 1955–1965.PubMedCrossRef

55.

Greiner, B., Sommerfeld, M., Kintscher, U., Unger, T., Kappert, K., & Kaschina, E. (2022). Differential regulation of MMPs, apoptosis and cell proliferation by the cannabinoid receptors CB1 and CB2 in vascular smooth muscle cells and cardiac myocytes. Biomedicines, 10(12), 3271.PubMedPubMedCentralCrossRef

56.

Chaves, E. A., Fortunato, R. S., Carvalho, D. P., Nascimento, J. H. M., & Oliveira, M. F. (2013). Exercise-induced cardioprotection is impaired by anabolic steroid treatment through a redox-dependent mechanism. Journal of Steroid Biochemistry and Molecular Biology, 138, 267–272.PubMedCrossRef

57.

Morán, M., Delgado, J., González, B., Manso, R., & Megías, A. (2004). Responses of rat myocardial antioxidant defences and heat shock protein HSP72 induced by 12 and 24-week treadmill training. Acta Physiologica Scandinavica, 180(2), 157–166.PubMedCrossRef

58.

Pozzi, R., Rosa, J. C., Eguchi, R., Oller Do Nascimento, C. M., Oyama, L. M., Aguiar, O., et al. (2010). Genetic damage in multiple organs of acutely exercised rats. Cell Biochemistry and Function, 28(8), 632–636.PubMedCrossRef

59.

Pey, A., Saborido, A., Blazquez, I., et al. (2003). Effects of prolonged stanozolol treatment on antioxidant enzyme activities, oxidative stress markers and heat shock protein HSP72 levels in rat liver. Journal of Steroid Biochemistry and Molecular Biology, 87, 269–277.PubMedCrossRef

60.

Okere, O. S., Adams, M. D., Tarfa, F. D., & Eze, E. D. (2017). Biochemical and histological changes in kidney and heart of male rats following oral administration of aqueous and methanolic extract of cannabis sativa leaves. EJBPS, 4(11), 59–67.

61.

Ahmed, M. A. E. (2015). Amelioration of nandrolone decanoate-induced testicular and sperm toxicity in rats by taurine: Effects on steroidogenesis, redox and inflammatory cascades, and intrinsic apoptotic pathway. Toxicology and Applied Pharmacology, 282(3), 285–296.PubMedCrossRef

62.

Tsai, K., Hsu, T. G., Hsu, K. M., Cheng, H., Liu, T. Y., Hsu, C. F., & Kong, C. W. (2001). Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radical Biology and Medicine, 31(11), 1465–1472. https://doi.org/10.1016/s0891-5849(01)00729-8CrossRefPubMed

63.

Tsai, K., Hsu, T. G., Hsu, K. M., Cheng, H., Liu, T. Y., Hsu, C. F., et al. (2001). Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radical Biology & Medicine, 31(11), 1465–1472.CrossRef

64.

Demirbag, R., Yilmaz, R., Gur, M., Celik, H., Guzel, S., Selek, S., et al. (2006). DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. International Journal of Clinical Practice, 60(10), 1187–1193.PubMedCrossRef

65.

Ebuehi, O. A. T. S. A. (2011). Cannabis sativa and ‘Karole’ induced oxidative stress and altered brain serotonin in adult Wistar rats. Nigerian Quarterly Journal of Hospital Medicine, 24(3), 205.

66.

Khadrawy, Y. A., & Abdel-Salam, O. M. E. H. E. (2017). Cannabis exacerbates depressive symptoms in rat model induced by reserpine. Behavioural Brain Research, 2(324), 41–50.CrossRef

67.

Ramel, A., Wagner, K. H., & Elmadfa, I. (2004). Plasma antioxidants and lipid oxidation after submaximal resistance exercise in men. European Journal of Nutrition, 43(1), 2–6.PubMedCrossRef

68.

Pozzi, R., Rosa, J. C., Eguchi, R., et al. (2010). Genetic damage in multiple organs of acutely exercised rats. Cell Biochemistry and Function, 28(8), 632.PubMedCrossRef

69.

Arazi, H., Mohammadjafari, H., & Asadi, A. (2017). Use of anabolic androgenic steroids produces greater oxidative stress responses to resistance exercise in strength-trained men. Toxicology Reports, 4(1), 282–286. https://doi.org/10.1016/j.toxrep.2017.05.005CrossRefPubMedPubMedCentral

70.

Simoncini, T., Mannella, P., Fornari, L., Varone, G., Caruso, A., & Genazzani, A. R. (2003). Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology, 144(8), 3449–3455.PubMedCrossRef

Title: Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice
Authors: Noha A. Mowaad
Rania Elgohary
Shaimaa ElShebiney
Publication date: 08-05-2024
Publisher: Springer US
Published in: Cardiovascular Toxicology / Issue 6/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-024-09859-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2024

Betaine Protects Mice from Cardiotoxicity Triggered by Sodium Arsenite Through Antioxidative and Anti-inflammatory Pathways

Correction: Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies

USP18 Curbs the Progression of Metabolic Hypertension by Suppressing JAK/STAT Pathway

SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs

Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab

Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page